Gail R. Wilensky - 27 Jul 2021 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role
Director
Signature
William J. O'Shaughnessy, Jr., Attorney in Fact for Gail R. Wilensky
Issuer symbol
DGX
Transactions as of
27 Jul 2021
Net transactions value
-$1,702,470
Form type
4
Filing time
28 Jul 2021, 16:18:33 UTC
Previous filing
06 Jul 2021
Next filing
23 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Options Exercise $351,780 +6,111 +34% $57.56 23,956 27 Jul 2021 Direct
transaction DGX Common Stock Sale $851,403 -6,111 -26% $139.32 17,845 27 Jul 2021 Direct F1
transaction DGX Common Stock Options Exercise $374,146 +6,111 +34% $61.22 23,956 27 Jul 2021 Direct
transaction DGX Common Stock Sale $851,067 -6,111 -26% $139.27 17,845 27 Jul 2021 Direct F2
holding DGX Common Stock 13,375 27 Jul 2021 by Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DGX Stock Options (Right to Buy) Options Exercise $351,780 -6,111 -100% $57.56 0 27 Jul 2021 Common Stock 6,111 $57.56 Direct F3
transaction DGX Stock Options (Right to Buy) Options Exercise $374,146 -6,111 -100% $61.22 0 27 Jul 2021 Common Stock 6,111 $61.22 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $139.28 to $139.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $139.26 to $139.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 The options vested in three annual installments beginning with the first on May 11, 2013, the second on May 11, 2014 and the final on May 11, 2015.
F4 The options vested in three annual installments beginning with the first on May 21, 2014, the second on May 21, 2015 and the final on May 21, 2016.